|
LMFA03010245
|
13,14-dihydro-15-keto-tetranor Prostaglandin D2
|
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
298.18
|
C16H26O5
|
|
LMFA03010246
|
13,14-dihydro-15-keto-tetranor Prostaglandin E2
|
11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
298.18
|
C16H26O5
|
|
LMFA03010264
|
2,3,4,5-tetranor PGF3alpha
|
9S,11S,15S trihydroxy-2,3,4,5-tetranorprosta-13,17-dienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
298.18
|
C16H26O5
|
|
LMFA03010215
|
Tetranor-PGD1
|
2,3,4,5-tetranor-9S,15S-dihydroxy-11-oxo-13E-prostenoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
298.18
|
C16H26O5
|
|
LMFA03010211
|
Tetranor-PGE1
|
2,3,4,5-tetranor-9-oxo-11R,15S-dihydroxy-13E-prostenoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
298.18
|
C16H26O5
|
|
LMFA03010265
|
alpha-tetranor 15keto-13,14-dihydro PGF3alpha
|
9S,11R-dihydroxy-15-keto-2,3,4,5-tetranorprosta-17Z-enoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
298.18
|
C16H26O5
|